Evaxion applies its AI-Immunology(TM) platform in autoimmune diseases
September 14, 2026
First Wave BioPharma Announces AAPS 2022 PharmSci 360 Accepts Adrulipase Formulation Abstract
August 31, 2022
Related Post
-
-
Tempest Therapeutics Announces Up to $7.5 Million Private Placement
September 11, 2026
-
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
September 11, 2026
-
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical’s FDA-Cleared Robotic TMS System
September 11, 2026